NAU-24098-63763
3 vaccinations
3 coded responses
38 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 458 / OH
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Moderna
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Injection site urticaria, Urticaria — Feeling: GoodFree text: Exactly a week after I had the vaccine, I developed a large hive above the injection site and a large hive below the injection site. Both cleared up within 12 hours after appearing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-02-05
Dose 2 — Moderna
- 2021-02-05
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body achesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-07
- 2021-08-06
-
2021-10-22
Dose 3 — ModernaCo-administered: Flu
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-28
- 2021-12-03
- 2022-01-21
- 2022-04-22
-
2022-10-24
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-10-22 | Moderna | Flu |
Free text
Release 2 — day 14, dose 1
Symptoms: Exactly a week after I had the vaccine, I developed a large hive above the injection site and a large hive below the injection site. Both cleared up within 12 hours after appearing.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Loss of appetite
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site urticaria | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ○ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release